From: Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis
Characteristic | No. of cases | TG(mmol/L) | χ2 | p value | |
---|---|---|---|---|---|
 ≤ 1.70 |  > 1.70 | ||||
Age | |||||
 ≤ 60 | 120 | 84 (70.0) | 36 (30.0) |  |  |
 > 60 | 212 | 146 (68.9) | 66 (31.1) | 0.046 | 0.830 |
Gender | |||||
 Male | 128 | 90 (70.3) | 38 (29.7) |  |  |
 Female | 204 | 140 (68.6) | 64 (31.4) | 0.105 | 0.746 |
Tumor invasion | |||||
 T1 | 31 | 27 (87.1) | 4 (12.9) |  |  |
 T2 | 81 | 50(61.7) | 31 (38.3) |  |  |
 T3 | 200 | 143 (71.5) | 57 (28.5) |  |  |
 T4 | 20 | 10 (50.0) | 10 (50.0) | 10.75 | 0.013* |
Lymph node metastasis | |||||
 N0 | 178 | 127 (71.3) | 51 (28.7) |  |  |
 N1 | 119 | 78 (65.5) | 41 (34.5) |  |  |
 N2 | 35 | 25 (71.4) | 10 (28.6) | 1.213 | 0.545 |
Metastasis | Â | ||||
 M0 | 304 | 215 (70.7) | 89(29.3) |  |  |
 M1 | 28 | 15 (53.5) | 13 (46.4) | 3.544 | 0.06 |